A Single Dose, Cross-over Bioequivence Study Comparing Galantamine IR (Immediate Release) Table and Galantmine OS (Oral Solution) in Healthy Volunteers

NCT00645554 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
2
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Xian-Janssen Pharmaceutical Ltd.